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Abstract
Background There are several life-threatening compli-
cations associated with intravenous thrombolysis after
acute ischemic stroke such as symptomatic intracerebral
hemorrhage, orolingual angioedema, or less frequent,
bleedings of the mucosa or ecchymosis. Aside from these
known critical incidents, rare and unfamiliar complications
may be even more challenging, as they are unexpected and
may mimic events that appear more frequently. We report a
rare and unusual acute complication of intravenous
thrombolysis with recombinant tissue plasminogen activa-
tor (rt-PA) (0.9 mg/kg) administered for acute ischemic
stroke.
Methods Medical records, radiologic imaging, and path-
ologic specimens were reviewed.
Results A 86-year-old woman developed acute respira-
tory failure 20 h after thrombolysis with suspected
angioedema triggered by intravenous rt-PA. The inspira-
tory stridor and dyspnea were unresponsive to
bronchodilators, corticosteroids, and inhaled adrenaline.
After endotracheal intubation, laryngoscopy showed no
significant supraglottic narrowing. Thyroidal sonography
and cervical computed tomography revealed a thyroidal
mass causing a tracheal and vascular compression com-
patible with thyroidal hemorrhage. Sonography showed a
nodular goiter of the right thyroid gland. A total thyroid-
ectomy was performed and histologic analysis confirmed a
hemorrhage of the right thyroidal lobe.
Conclusions Acute airway obstruction with respiratory
failure due to thyroidal hemorrhage after intravenous
thrombolysis is an important life-threatening complication,
mimicking an anaphylactic reaction or a more frequent
orolingual angioedema.
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Introduction
There are several challenging and life-threatening com-
plications associated with intravenous thrombolysis after
acute ischemic stroke that may worsen outcome, such as
symptomatic intracerebral hemorrhage, orolingual angioe-
dema, or less frequent mucosa bleedings or ecchymosis, as
well as acute myocardial rupture when intravenous
recombinant tissue plasminogen activator (rt-PA) is given
in the setting of subacute myocardial infarction [1]. How-
ever, there are other rare complications which may be even
more challenging, as they remain unexpected and may
mimic events that appear more frequently.
We report an unusual complication of intravenous
thrombolysis with rt-PA (0.9 mg/kg) administered for
acute ischemic stroke.
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Case
An 86-year-old woman presented with a sudden onset of a
left-sided weakness and dysarthria. Her past medical his-
tory was relevant for arterial hypertension and mitral
regurgitation. Initial head computed tomography (CT)
showed a hyperdense middle cerebral artery sign of the
right M1-segment, suspicious for a thromboembolic
occlusion, and excluded an intracerebral hemorrhage.
Neurologic examination revealed a sensomotoric, facio-
brachial left hemiparesis with an ipsilateral hemineglect
and dysarthria. The National Institutes of Health Stroke
Scale (NIHSS) was 11. Intravenous thrombolysis was
administered with weight-adapted rt-PA 60 min after
admission, and 260 min after symptom onset, with an
immediate neurofunctional improvement (NIHSS 4) except
for a persisting proximal weakness of the left arm and an
ipsilateral incomplete facial paresis. Follow-up head CT
revealed no hemorrhagic transformation or intracerebral
bleeding. Newly diagnosed atrial fibrillation corroborated
the etiological hypothesis of a thromboembolic cause of the
stroke.
Twenty hours after intravenous rt-PA was given, the
patient developed acute respiratory failure with an inspi-
ratory stridor and dyspnea. These symptoms were
unresponsive to bronchodilators, corticosteroids, and
inhaled adrenaline. After endotracheal intubation, laryn-
goscopy showed no supraglottic narrowing, ruling out an
orolingual angioedema. Thyroidal sonography detected an
enlarged hyperechogenic thyroid gland and cervical CT
revealed a thyroidal homogenous hypodense mass (Fig. 1,
white arrows) including smaller hyperdensities (Fig. 2a,
white arrows) causing a tracheal and vascular compression
(Fig. 2a, black arrows) compatible with thyroidal hemor-
rhage. In addition, sonography showed a nodular goiter of
the right thyroid gland. Therefore, a total thyroidectomy
was performed. Histologic examination revealed multiple
nodules and a hemorrhage of the right thyroid (Fig. 3a–d).
The left thyroid gland appeared unremarkable and there
was no evidence of malignancy on both sides. One day
after the thyroidectomy, the patient was extubated and had
no signs of airway obstruction but a deterioration of the
weakness with a left-sided hemiplegia. A follow-up head
CT revealed a slight expansion and hemorrhagic transfor-
mation of the infarct into the centrum semiovale. During
the following 2 weeks, the patient’s dysarthria and weak-
ness gradually decreased with a remaining, ataxic,
faciobrachial paresis, and she was discharged to a
Fig. 1 Sagittal cervical computed tomography showing a thyroidal
homogenous hypodense mass with focal tracheal and vascular
compression (white arrows)
Fig. 2 Transversal cervical computed tomography. a Thyroidal
homogenous hypodense mass including smaller hyperdensities (white
arrows) with tracheal and vascular compression (black arrows). b
Intratracheal tube below the area of compression
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rehabilitation center with a Medical Research Council scale
of 4/5 in her left arm. After 1 month of stationary reha-
bilitation, the patient recovered completely with the
exception of a persistent, subtle, ataxic gait. Two years
after the stroke the patient has fully recovered and living
independently on her own.
Discussion
This is the first case report of an isolated thyroidal hem-
orrhage complicating intravenous thrombolysis following
ischemic stroke. The most deleterious and life-threatening
complication after thrombolysis in this setting is a symp-
tomatic intracerebral hemorrhage, which occurs in 6–15 %
of patients [2, 3] and is associated with unfavorable out-
come [4–6]. Hemorrhagic transformation of strokes, on the
other hand, is reported to be far more frequent (8–35 %)
and mostly remains clinically asymptomatic [7, 8].
Orolingual angioedema is reported in 1.5–5 % of stroke
patients treated with intravenous rt-PA [9, 10]. Less fre-
quent complications are bleedings of the mucosa or
ecchymosis.
Thyroidal hemorrhage with relevant compression of
surrounding structures is rare and mostly iatrogenic or
caused by trauma. Some reports describe thyroidal hem-
orrhage related to oral anticoagulation or coexisting
thyroidal toxicosis [11, 12]. To date, there are few reports
of spontaneous hemorrhage in thyroid goiter and only one
case report of thyroidal hemorrhage following thromboly-
sis after myocardial infarction [13], reflecting that thyroid
hemorrhage is a rare complication of intravenous throm-
bolysis. However, physicians should be aware of this life-
threatening complication, as early recognition and rapid
intervention can lead to good outcome. Despite this com-
plication, our patient had a good neurofunctional recovery
and long-term outcome after intravenous thrombolysis and
rehabilitation.
Fig. 3 Thyroidectomy specimen. a, c Macroscopic images of cut
surfaces of the thyroidectomy specimen with a large central
hemorrhage. b, d Whole mount histologic section revealing nodular
hyperplasia (gray arrows) with a fresh central hemorrhage (black
arrows) (hematoxylin–eosin)
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Conclusions
Acute respiratory failure due to thyroidal hemorrhage after
intravenous thrombolysis is an important life-threatening
complication, mimicking an anaphylactic reaction or more
frequent orolingual angioedema.
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